Evidence to Consider when Advising Patients on Buprenorphine Treatment Duration for Opioid Use Disorder
Presenters: Ingrid A. Binswanger, MD, MPH, MS and Jason M. Glanz, PhD, MS, both from Institute for Health Research (Kaiser Permanente). More about the speakers
Retention on buprenorphine for opioid use disorder is known to be poor across health systems, despite established mortality benefits of treatment, and little is known about how to counsel patients who want to stop using buprenorphine or who have to stop due to barriers to ongoing care.
This webinar will consider what the evidence from a prescription opioid registry developed by NIDA Clinical Trials Network study CTN-0084 suggests for individuals who discontinue buprenorphine, including whether there was a length-of-treatment exposure associated with improved outcomes. Implications for patient education and shared decision-making will be considered. Understanding the optimal length of treatment after which individuals can safely discontinue buprenorphine could help patients better understand what treatment might look like at the outset, supporting…
Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/webinar/register/WN_tpK22hL2TnuTz-VZspOd9Q. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars.
Wednesday, July 29, 2026, 11:00 AM – 12:30 PM.
Webinar - register at: https://washington.zoom.us/webinar/register/WN_tpK22hL2TnuTz-VZspOd9Q.
Frontline Conversations Series: Involuntary SUD Treatment in WA: When and How?
Join this 4-part webinar series, Frontline Conversations: Advancing SUD Care in Clinical Practice, facilitated by Mark Duncan, MD and Maureen Oscadal, RN, MPH, BSN, to explore emerging practices in the care of people living with substance use disorder (SUD).
This series features brief presentations and panel discussions with expert community providers on the topics listed below. A Q&A session for all participants will take place after the facilitated discussion.
August 5, 2026: Involuntary SUD Treatment in WA: When and How?
Panelists TBD!
Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/meeting/register/F244UTQKRHSvq_BceALmyA#/registration. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars.
Wednesday, August 5, 2026, 12:00 PM – 1:30 PM.
Webinar - register at: https://washington.zoom.us/meeting/register/F244UTQKRHSvq_BceALmyA#/registration.
Recovery Coaching for Faith-Based Communities
Presenters: Pete Villanueva and Becky Gonzales (both of Recovery Cafe of Clark County). More about the speakers.
All faith-based communities are invited!
Are you ready to make a deeper, lasting impact in the lives of those seeking recovery?
We invite you and your organization to experience the power of Recovery Coaching—a compassionate, person-centered approach that meets individuals where they are.
“People are in recovery if and when they say they are.”
Recovery is not one-size-fits-all. It can include:
Substance use (including alcohol), Mental health challenges, Grief and loss, Obsessive behaviors, Trauma, Join us for an engaging and informative presentation where you’ll discover how Recovery Coaching can strengthen your ministry, expand your outreach, and better support those on their journey toward healing. We would be honored to partner with you in this important work.
Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/webinar/register/WN_ja4Aose1RDqRZ9JxGzZjSg. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars.
Wednesday, August 26, 2026, 12:00 PM – 1:00 PM.
Webinar - register at: https://washington.zoom.us/webinar/register/WN_ja4Aose1RDqRZ9JxGzZjSg.
The Dose Makes the Poison: Cannabinoid Hyperemesis Syndrome Goes Mainstream
CME accreditation pending for providers; Certificate of attendance available for both in-person and virtual attendees
Cannabinoid Hyperemesis Syndrome (CHS) is becoming increasingly visible in clinical settings, but many providers are navigating diagnosis, treatment, and patient communication without clear guidance.
In a recent survey of Washington State healthcare providers, 70% reported treating patients experiencing severe abdominal pain, persistent nausea, retching, and relentless vomiting associated with heavy cannabis use.
Patients may not recognize cannabis as the cause of their symptoms, or may be skeptical that CHS exists at all, making effective care even more challenging.
Join the UW Addictions, Drug & Alcohol Institute (ADAI) on September 18, 2026, to for this FREE one-day symposium about:
What we know about CHS in Washington State and the U.S.—prevalence in hospitals, emergency departments, and community settings Recognition, diagnosis, treatment, and management across healthcare…
Event interval: Single day event. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars.
Friday, September 18, 2026, 9:00 AM – 4:00 PM.
Virtual or at the UW Tower Auditorium (NE 45th St and Brooklyn Ave NE).
For more info visit adai.uw.edu. First Responder Wellness Summit: Caring for Ourselves During the Overdose Crisis
This free one-day summit brings together professionals from law enforcement, fire, EMS, corrections, co-response teams, dispatch, and peer support to explore how to strengthen first responder well-being amidst the current drug overdose crisis and in their lives more broadly.
Learn more about the speakers and breakout options here.
We have limited parking assistance funds available. If parking on campus would present a barrier to your attendance please indicate this during registration. Assistance will be provided on a first-come, first-served basis.
Contact nbranche@uw.edu for questions or for accommodation requests.
Event interval: Single day event. Accessibility Contact: Nicole Branche, nbranche@uw.edu. Event Types: Conferences.
Wednesday, September 23, 2026, 8:00 AM – 3:45 PM.
UW Student Union Building (HUB)
HUB Ballroom
4001 E. Stevens Way NE
Seattle, WA 98195.
For more info visit adai.uw.edu.